ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/083/SRR29069383/SRR29069383.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/086/SRR29069386/SRR29069386.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/077/SRR29069377/SRR29069377.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/075/SRR29069375/SRR29069375.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/088/SRR29069388/SRR29069388.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/080/SRR29069380/SRR29069380.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/078/SRR29069378/SRR29069378.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/073/SRR29069373/SRR29069373.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/084/SRR29069384/SRR29069384.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/076/SRR29069376/SRR29069376.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/087/SRR29069387/SRR29069387.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/082/SRR29069382/SRR29069382.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/074/SRR29069374/SRR29069374.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/081/SRR29069381/SRR29069381.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/079/SRR29069379/SRR29069379.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR290/085/SRR29069385/SRR29069385.fastq.gzprimary200OKGenomicsChildren’s Hospital of Soochow Universityhttps://www.ebi.ac.uk/ena/browser/view/PRJNA1112807Homo sapiensMany key oncogenes have been reported to be driven by super-enhancers. To explore novel oncogenes, ChIP-seq for H3K27ac profiling and super-enhancer analysis was conducted in T-ALL cells. Overall design: ChIP using antibody against H3K27ac in J.gamma1 cells and bone marrow cells from T-ALL patients.xref:PubMed:39454110ENAfalseRoles of super-enhancer-driven genes in T-ALL cellsRoles of super-enhancer-driven genes in T-ALL cells2025-09-242024-10-29PRJNA1112807GSE267758960639454110